We are live on ! Find out more
Ray Dalio

Ray Dalio Bridgewater Associates

AUM $22.4B
1-Year Est. Return 34.48%
 

Ray Dalio is the founder of Bridgewater Associates, one of the world’s largest hedge funds, known for its unique “principles-based” culture and systematic investment approach. Dalio’s investment philosophy emphasizes diversified portfolios, risk parity, and the importance of understanding economic cycles in shaping investment decisions. He has authored several books, including “Principles: Life & Work,” in which he details his management philosophies, personal experiences, and life lessons.

This Fund
S&P 500
This Quarter Est. Return
-0.7%
1 Year Est. Return
+34.48%
3 Year Est. Return
+84.29%
5 Year Est. Return
+89.92%
10 Year Est. Return
+230.06%
AUM
$10.5B
AUM Growth
-$1.73B
Cap. Flow
-$1.74B
Cap. Flow %
-16.59%
Top 10 Hldgs %
73.24%
Holding
508
New
262
Increased
77
Reduced
116
Closed
48

Sector Composition

Rank Sector Weight
1 Healthcare 3.02%
2 Energy 2.11%
3 Consumer Discretionary 2.02%
4 Financials 1.95%
5 Consumer Staples 1.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZION icon
251
Zions Bancorporation
ZION
$10.3B
$1.14M 0.01%
+21,603
New +$1.16M
NUE icon
252
Nucor
NUE
$62.1B
$1.12M 0.01%
18,390
-21,702
-54% -$1.44M
PWR icon
253
Quanta Services
PWR
$101B
$1.11M 0.01%
+32,398
New +$1.17M
DLX icon
254
Deluxe
DLX
$1.15B
$1.11M 0.01%
+15,019
New +$1.11M
NWSA icon
255
News Corp Class A
NWSA
$15.4B
$1.1M 0.01%
+69,845
New +$1.15M
CVE icon
256
Cenovus Energy
CVE
$52.1B
$1.1M 0.01%
129,279
-2,688
-2% -$23.7K
MORN icon
257
Morningstar
MORN
$7.53B
$1.09M 0.01%
+11,403
New +$1.1M
WLY icon
258
John Wiley & Sons Class A
WLY
$2.66B
$1.09M 0.01%
+17,075
New +$1.11M
OC icon
259
Owens Corning
OC
$12.4B
$1.08M 0.01%
+13,433
New +$1.17M
CMA
260
DELISTED
Comerica
CMA
$1.07M 0.01%
+11,126
New +$1.06M
IDXX icon
261
Idexx Laboratories
IDXX
$46.2B
$1.05M 0.01%
+5,495
New +$1.01M
MTB icon
262
M&T Bank
MTB
$36.2B
$1.03M 0.01%
+5,604
New +$1.04M
PGR icon
263
Progressive
PGR
$125B
$1.03M 0.01%
+16,930
New +$967K
PFG icon
264
Principal Financial Group
PFG
$24.3B
$1.01M 0.01%
+16,622
New +$1.09M
WRK
265
DELISTED
WestRock Company
WRK
$995K 0.01%
+15,501
New +$1.02M
CFR icon
266
Cullen/Frost Bankers
CFR
$10.2B
$983K 0.01%
+9,270
New +$968K
ALGN icon
267
Align Technology
ALGN
$12.3B
$975K 0.01%
+3,881
New +$997K
PKG icon
268
Packaging Corp of America
PKG
$22.8B
$972K 0.01%
+8,621
New +$1.04M
FITB
269
Fifth Third Bancorp
FITB
$51.8B
$969K 0.01%
+30,505
New +$996K
HBAN icon
270
Huntington Bancshares
HBAN
$35.5B
$957K 0.01%
+63,352
New +$996K
RMD icon
271
ResMed
RMD
$30.7B
$948K 0.01%
+9,632
New +$910K
HSIC icon
272
Henry Schein
HSIC
$9.82B
$940K 0.01%
+17,825
New +$988K
STE icon
273
Steris
STE
$23.1B
$939K 0.01%
+10,060
New +$915K
THC icon
274
Tenet Healthcare
THC
$21.1B
$937K 0.01%
+38,658
New +$770K
HRC
275
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$936K 0.01%
+10,759
New +$920K

Similar funds

Ray Dalio's Q1 2018 Portfolio in Review

As of Q1 2018, Ray Dalio held 508 positions worth $10.5B, down 14% from $12.2B the previous quarter. Its ten largest holdings account for 73% of the portfolio.

Ray Dalio withdrew a net $1.74B in Q1 2018, closing 48 positions and reducing 116 holdings. Its most notable exit was Costco, an estimated $15.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 3% of assets, up from 1.7% a quarter earlier, followed by Energy and Consumer Discretionary.

Against the trend, Ray Dalio opened a new position in Biogen worth $21.1M.

  • Ray Dalio's largest Q1 2018 buy was Biogen: 77,197 shares worth $21.1M.
  • Ray Dalio added most to Newfield Exploration in Q1 2018, an estimated $44.6M increase.
  • Ray Dalio's biggest Q1 2018 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $1.04B.
  • Ray Dalio fully exited Costco in Q1 2018, selling an estimated $15.6M.
  • Ray Dalio's ten largest holdings make up 73% of its $10.5B portfolio in Q1 2018.
  • Ray Dalio opened 262 new positions and closed 48 in Q1 2018.
  • Ray Dalio's portfolio value fell 14% quarter-over-quarter to $10.5B.

Based on Bridgewater Associates's 13F filing for Q1 2018, filed 15 May 2018.